FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2961431639> ?p ?o ?g. }

• W2961431639 endingPage "235" @default.
• W2961431639 startingPage "228" @default.
• W2961431639 abstract "Background : Neutrophil activation is a mandatory stage and a sensitive marker of systemic inflammatory response. The development of this condition is associated with subsequent multiple organ failure which is the main indication for the patients stay in the intensive care unit. The search for drugs that could prevent the development of systemic inflammatory response and reduce mortality remains an urgent task of anesthesiology/resuscitation. Aim : To study the anti-inflammatory effect of dalargin, a synthetic analogue of lei-enkephalin, on human neutrophils in vitro. Materials and methods : The study was performed on blood neutrophils isolated from 5 healthy donors. A proportion of neutrophils were activated by 10 mkM formil-Met-Leu-Pro (fMLP) and 100 ng/mL lipopolysaccharide (LPS) with subsequent assessment of their activity by fluorescent antibodies to the degranulation markers CD11b and CD66b. Thereafter intact and activated neutrophils were treated with dalargin solution at concentrations of 50 and 100 mcg/mL. Results : Dalargin at 100 mcg/mL reduced the expression of CD11b molecules on the surface of intact neutrophils by 5.5-fold (p=0.008). On the contrary, LPS at a dose of 100 ng/mL increased the expression of the same molecules by 46% (p=0.08). The addition of dalargin at 50 mcg/mL to LPS-activated neutrophils reduced the expression of CD11b molecules (p=0.016). The addition of dalargin at 50 mcg/mL to fMLP-activated neutrophils significantly (p=0.008) reduced the expression of CD11b molecules and reversed their expression virtually to the level of the control. The addition of dalargin at 100 mcg/mL to neutrophils activated by fMLP at 10 mkM reduced the expression of CD11b on their surface to a level below the control by 23% (p=0.08). Conclusion : Dalargin at the studied concentrations has an anti-inflammatory effect on both intact and pre-activated bacterial components of neutrophils, thus inhibiting the process of activation and degranulation in a dose-dependent manner." @default.
• W2961431639 created "2019-07-23" @default.
• W2961431639 creator A5002143616 @default.
• W2961431639 creator A5022640690 @default.
• W2961431639 creator A5054806767 @default.
• W2961431639 creator A5079395063 @default.
• W2961431639 creator A5086083299 @default.
• W2961431639 creator A5091641056 @default.
• W2961431639 date "2019-07-31" @default.
• W2961431639 modified "2023-09-25" @default.
• W2961431639 title "Synthetic leu-enkefalin analogue prevents activation of neutrophils induced by a bacterial component" @default.
• W2961431639 cites W1659623810 @default.
• W2961431639 cites W1867471385 @default.
• W2961431639 cites W1984213393 @default.
• W2961431639 cites W2029520101 @default.
• W2961431639 cites W2031553202 @default.
• W2961431639 cites W2034879954 @default.
• W2961431639 cites W2035133891 @default.
• W2961431639 cites W2048654159 @default.
• W2961431639 cites W2049948016 @default.
• W2961431639 cites W2053721185 @default.
• W2961431639 cites W2055750901 @default.
• W2961431639 cites W2057824614 @default.
• W2961431639 cites W2061730726 @default.
• W2961431639 cites W2067489599 @default.
• W2961431639 cites W2090915852 @default.
• W2961431639 cites W2120728709 @default.
• W2961431639 cites W2324627768 @default.
• W2961431639 cites W2437150123 @default.
• W2961431639 cites W2594439935 @default.
• W2961431639 cites W2804017496 @default.
• W2961431639 doi "https://doi.org/10.18786/2072-0505-2019-47-026" @default.
• W2961431639 hasPublicationYear "2019" @default.
• W2961431639 type Work @default.
• W2961431639 sameAs 2961431639 @default.
• W2961431639 citedByCount "3" @default.
• W2961431639 countsByYear W29614316392021 @default.
• W2961431639 countsByYear W29614316392022 @default.
• W2961431639 crossrefType "journal-article" @default.
• W2961431639 hasAuthorship W2961431639A5002143616 @default.
• W2961431639 hasAuthorship W2961431639A5022640690 @default.
• W2961431639 hasAuthorship W2961431639A5054806767 @default.
• W2961431639 hasAuthorship W2961431639A5079395063 @default.
• W2961431639 hasAuthorship W2961431639A5086083299 @default.
• W2961431639 hasAuthorship W2961431639A5091641056 @default.
• W2961431639 hasBestOaLocation W29614316391 @default.
• W2961431639 hasConcept C126322002 @default.
• W2961431639 hasConcept C16685009 @default.
• W2961431639 hasConcept C170493617 @default.
• W2961431639 hasConcept C171779818 @default.
• W2961431639 hasConcept C198677920 @default.
• W2961431639 hasConcept C202751555 @default.
• W2961431639 hasConcept C203014093 @default.
• W2961431639 hasConcept C2776914184 @default.
• W2961431639 hasConcept C2778165595 @default.
• W2961431639 hasConcept C2778384902 @default.
• W2961431639 hasConcept C2778754761 @default.
• W2961431639 hasConcept C42219234 @default.
• W2961431639 hasConcept C49802076 @default.
• W2961431639 hasConcept C553184892 @default.
• W2961431639 hasConcept C55493867 @default.
• W2961431639 hasConcept C71924100 @default.
• W2961431639 hasConcept C86803240 @default.
• W2961431639 hasConcept C98274493 @default.
• W2961431639 hasConceptScore W2961431639C126322002 @default.
• W2961431639 hasConceptScore W2961431639C16685009 @default.
• W2961431639 hasConceptScore W2961431639C170493617 @default.
• W2961431639 hasConceptScore W2961431639C171779818 @default.
• W2961431639 hasConceptScore W2961431639C198677920 @default.
• W2961431639 hasConceptScore W2961431639C202751555 @default.
• W2961431639 hasConceptScore W2961431639C203014093 @default.
• W2961431639 hasConceptScore W2961431639C2776914184 @default.
• W2961431639 hasConceptScore W2961431639C2778165595 @default.
• W2961431639 hasConceptScore W2961431639C2778384902 @default.
• W2961431639 hasConceptScore W2961431639C2778754761 @default.
• W2961431639 hasConceptScore W2961431639C42219234 @default.
• W2961431639 hasConceptScore W2961431639C49802076 @default.
• W2961431639 hasConceptScore W2961431639C553184892 @default.
• W2961431639 hasConceptScore W2961431639C55493867 @default.
• W2961431639 hasConceptScore W2961431639C71924100 @default.
• W2961431639 hasConceptScore W2961431639C86803240 @default.
• W2961431639 hasConceptScore W2961431639C98274493 @default.
• W2961431639 hasIssue "3" @default.
• W2961431639 hasLocation W29614316391 @default.
• W2961431639 hasOpenAccess W2961431639 @default.
• W2961431639 hasPrimaryLocation W29614316391 @default.
• W2961431639 hasRelatedWork W117348123 @default.
• W2961431639 hasRelatedWork W126906085 @default.
• W2961431639 hasRelatedWork W1540807868 @default.
• W2961431639 hasRelatedWork W1585072926 @default.
• W2961431639 hasRelatedWork W1954062662 @default.
• W2961431639 hasRelatedWork W1989374140 @default.
• W2961431639 hasRelatedWork W1997479744 @default.
• W2961431639 hasRelatedWork W2000303682 @default.
• W2961431639 hasRelatedWork W2000692847 @default.
• W2961431639 hasRelatedWork W2025156166 @default.
• W2961431639 hasRelatedWork W2037969580 @default.
• W2961431639 hasRelatedWork W2053224741 @default.

• next